{
  "docId": "019de074-01e2-758c-9358-12040e004419",
  "docSlug": "a93b7129565926c7be538a038211eae0",
  "documentTitle": "Larimar Therapeutics | Results Presentation Deck | 15 slides",
  "authorId": "larimar-therapeutics",
  "authorName": "Larimar Therapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 15,
  "prevPage": 14,
  "nextPage": null,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-01e2-758c-9358-12040e004419/15",
  "deckHref": "/decks/019de074-01e2-758c-9358-12040e004419",
  "deckJsonHref": "/decks/019de074-01e2-758c-9358-12040e004419.json",
  "deckAnchorHref": "/decks/019de074-01e2-758c-9358-12040e004419#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.24,
        "x": 0.69,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "These data support continued study of CTI-1601 for the treatment of patients with Friedreich's ataxia",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07063dad-eab8-4fc7-a0dd-858c2fb1e6bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.24,
        "x": 0.09,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "Subcutaneously administered CTI-1601 was generally well tolerated at daily doses up to 100 mg for 13 days",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89eb7538-41b6-4c7b-9d70-ca50c137c6ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.24,
        "x": 0.39,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "Pharmacokinetic data suggest that daily dosing may be required to maintain exposure",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdc8a254-c911-4b4e-bf98-91b48aaadb1e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.12,
        "x": 0.03,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "PK, pharmacokinetic.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1f145b4-346b-4e20-9d08-7f1ccd5bdffb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.25,
        "x": 0.025,
        "y": 0.035
      },
      "kind": "title",
      "text": "Conclusions",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26b35499-f109-4e10-b6b7-f5a29736d73a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 15,
      "beatId": "e7a2801d-7d77-41fe-87a4-5a26060e5daf",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "Conclusions and key takeaways",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}